you are viewing a single comment's thread.
Not much to say. Doomed to trade in the same $11 to $21 range for the next two years at least that it has for the past more than two years.
11 to 21 is very good if somebody buys it below 15. Even at these levels it means there is a potential of 20%.
If you buy here and it goes to 21, wouldn't that be over 27%?
That potential is unlikely to be attained, unless there is big positive surprise news, such as Bapi being approved.
Between March 2, 2009 and January 20, 2013, Pfizer figures to trade between $11.62 and $29.Between July 23, 2010 and January20, 2013, it figures to trade between $14 and $29.
It's simply ludicrous to imagine that PFE could possibly reach $29 by Jan 2013. Even $23 is a long shot by then.You are always laughably wrong, & will be again.Do you promise to leave this board forever immediately when PFE does not trade over $29 by that date?